The results showed that butyric acid exhibits a promising effect on 7,12-dimethylbenz[a]anthracene (DMBA)-induced tumor through increasing HDAC expression and activity, accompanied by upregulation of miR-203 promoter methylation at 4 or 16 weeks [226]. The gene discussed is HDAC9; the disease is neoplasm.